Brief: Iveric Bio And Delsitech Enter Exclusive Agreement For Development Of Sustained Release Zimura

IVERIC bio

05/07/2022 16:19

July 5 (Reuters) - Iveric Bio Inc  ISEE.O :
    * IVERIC BIO AND DELSITECH ENTER EXCLUSIVE AGREEMENT FOR
DEVELOPMENT OF SUSTAINED RELEASE ZIMURA®
    * IVERIC BIO - WILL PAY DELSITECH UPFRONT PAYMENT OF EUR
1,250,000, DEVELOPMENT & COMMERCIAL MILESTONES & ROYALTIES ON
NET SALES OF LICENSED PRODUCTS
    * IVERIC BIO - PLANS TO EXPLORE POTENTIAL FOR ZIMURA IN
EARLIER
STAGES OF AMD BY INITIATING TRIAL STUDYING ZIMURA IN PATIENTS
WITH INTERMEDIATE AMD IN Q4 2022

Source text for Eikon:  ID:nBw3bjRjra 
Further company coverage:  ISEE.O 

 ((Reuters.Briefs@thomsonreuters.com;))